Search results
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 17 hours agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 hours agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 6 hours agoModerna is rivaling vaccine makers Pfizer and Novavax. Still, the market for Covid boosters is...
Leerink Partnrs Comments on Pfizer Inc.’s Q2 2024 Earnings (NYSE:PFE)
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Pfizer in a report issued on Thursday ...
The CDC Took Out 148 Pages of Essential Information
Mercola· 6 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining ...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 1 day agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 4 days agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoBut as society learned to live with Covid...reached a recent low at 2590.87 on April 25, down 15%...
Why the WHO's Pandemic Treaty Should Set Off Your Alarm
Mercola· 16 hours agoThroughout COVID-19, the more money countries spent complying with the WHO’s guidelines for mitigating COVID-19, the more people died.1 Because of this, ...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 21 hours agoIn oncology, we are pleased with GenPath's performance due to its innovative testing platform with an expanded hematological malignancy panel and very...